Reduction of Lupus Nephritis in MRL/lpr Mice by a Bacterial Superantigen Treatment

Journal of Experimental Medicine - United States
doi 10.1084/jem.174.6.1431
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

ALW Peptide Ameliorates Lupus Nephritis in MRL/lpr Mice

Arthritis Research & Therapy
2019English

The New Complement Inhibitor CRIg/FH Ameliorates Lupus Nephritis in Lupus-Prone MRL/lpr Mice

BMC Nephrology
Nephrology
2019English

Reduced Receptor Editing in Lupus-Prone MRL/lpr Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
2007English

Activation-Induced Deaminase-Deficient MRL/lpr Mice Secrete High Levels of Protective Antibodies Against Lupus Nephritis

Arthritis & Rheumatism
2011English

Prevention of Nephritis in Major Histocompatibility Complex Class II- Deficient MRL-lpr Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1994English

Leptin Facilitates the Differentiation of Th17 Cells From MRL/Mp-Fas LPR Lupus Mice by Activating NLRP3 Inflammasome

Innate Immunity
Infectious DiseasesImmunologyMicrobiologyMolecular BiologyCell Biology
2019English

Regulation of Basement Membrane-Reactive B Cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr Lupus Mice

Autoimmunity
AllergyImmunology
2013English

IL-34–Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2019English

Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy